Watch PACB. Know when insiders buy.
One email the day a filing lands. Free.
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
1.58
+0.17 +12.06%
USD · close Sep 24
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
69
PASS · shorts 69
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $491.1MP/E —DIV YIELD —FCF YIELD -25.13%REV TTM —NET INCOME −$131.4MNET DEBT $835.8M52W 1.11 – 2.67SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $39M | −1.9% | 32.4% | −$44.6M | −$44.7M | — | -0.14 | −$35.6M | $1.6M | −$37.1M | Aug 6 |
| Q1 2026 · Mar 31 | $37.2M | +0.1% | 34.5% | −$8.4M | −$8.3M | — | -0.03 | −$44.7M | $3M | −$47.7M | May 8 |
| Q4 2025 · Dec 31derived | — | — | — | −$41.2M | −$40.4M | −1802.7% | -0.13 | −$19.1M | $861K | −$19.9M | Feb 25 |
| Q3 2025 · Sep 30 | $38.4M | −3.8% | 41.4% | −$38.9M | −$38M | — | -0.13 | −$18.7M | −$86K | −$18.6M | Nov 6 |
| Q2 2025 · Jun 30 | $39.8M | +10.4% | 36.9% | −$44.9M | −$41.9M | — | -0.14 | −$29.4M | $550K | −$29.9M | Aug 6 |
| Q1 2025 · Mar 31 | $37.2M | −4.3% | -3.7% | −$428.9M | −$426.1M | — | -1.44 | −$44.1M | $1.4M | −$45.4M | May 8 |
| Q4 2024 · Dec 31derived | — | — | — | −$153M | $2.4M | — | -0.44 | −$30.6M | $1.6M | −$32.3M | Feb 25 |
| Q3 2024 · Sep 30 | $40M | −28.2% | 25.0% | −$64.1M | −$60.7M | — | -0.22 | −$45.5M | −$787K | −$44.7M | Nov 6 |
| Q2 2024 · Jun 30 | $36M | — | 16.5% | −$175.8M | −$173.3M | — | -0.64 | −$54.3M | $1.5M | −$55.7M | Aug 7 |
| Q1 2024 · Mar 31 | $38.8M | — | 29.1% | −$81.4M | −$78.2M | — | -0.29 | −$75.7M | $3.9M | −$79.6M | May 12 |
| Q4 2023 · Dec 31derived | — | — | — | −$87.5M | −$82M | — | -0.31 | −$57.6M | $2M | −$59.6M | Feb 25 |
| Q3 2023 · Sep 30 | $55.7M | — | 32.1% | −$82.5M | −$66.9M | — | -0.26 | −$65.2M | $830K | −$66M | Nov 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$553.9M | −$546.4M | — | -1.82 | −$111.2M | $2.7M | −$113.9M | — | — |
| FY2024 · to Dec 31 | — | — | −$474.3M | −$309.9M | — | -1.59 | −$206.1M | $6.2M | −$212.2M | — | — |
| FY2023 · to Dec 31 | — | — | −$334.5M | −$306.7M | — | -1.21 | −$259.2M | $8.8M | −$268M | — | — |
| FY2022 · to Dec 31 | — | — | −$307.2M | −$314.2M | — | -1.40 | −$263.2M | $16.8M | −$280M | — | — |
| FY2021 · to Dec 31 | — | — | −$210.4M | −$181.2M | — | -0.89 | −$111.2M | $5.9M | −$117.1M | — | — |
| FY2020 · to Dec 31 | — | — | −$104.4M | $29.4M | — | 0.17 | $19.5M | $1M | $18.5M | — | — |
Every number comes from PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.